Dr. Martin Hirst is Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre, Director of the Michael Smith Laboratory and Professor at the University of British Columbia.
This interview, co-hosted by Alvin Qiu and Benjamin Lebeau, focuses on Dr. Hirst’s career and future perspectives on epigenetic approaches for cancer therapy.
To leave or reply to comments, please download free Podbean or
To leave or reply to comments,
please download free Podbean App.